BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.80
-1.30 (-4.05%)
At close: Aug 28, 2026

BIONET Therapeutics Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-84.09-97.43-86.26-37.34-12.52
Depreciation & Amortization
20.6811.773.240.58-
Loss (Gain) From Sale of Investments
-0.03-0.14-0.71-0.03-
Stock-Based Compensation
18.9218.693.710.16-
Provision & Write-off of Bad Debts
1.020.010.01--
Other Operating Activities
-1.1-1.64-4.99-1.6-
Change in Accounts Receivable
-15.24-13.24-10.27-1.17-
Change in Inventory
-9.11-0.56-29.15-0.37-
Change in Accounts Payable
3.07-9.1711.614.551.17
Change in Unearned Revenue
16.666.981.712.61-
Change in Other Net Operating Assets
2.8313.842.69-1.557.87
Operating Cash Flow
-38.46-57.48-124.39-34.16-3.47
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-52.33-81.19-46.56-12.1-
Sale (Purchase) of Intangibles
-4.94-2-0.46--
Investment in Securities
109.45219-707.09-478.99-
Other Investing Activities
0.05-0.06-0.68-0.01-
Investing Cash Flow
52.23135.75-754.8-491.09-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Repaid
--0.71---
Net Debt Issued (Repaid)
-2.25-0.71---
Issuance of Common Stock
--855.85516.5796
Financing Cash Flow
-2.25-0.71855.85516.5796

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
11.5277.56-23.33-8.6792.53

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-90.79-138.68-170.95-46.26-3.47
Free Cash Flow Growth
-----
Free Cash Flow Margin
-46.17%-89.77%-210.22%-861.52%-
Free Cash Flow Per Share
-1.29-1.98-2.98-3.06-3.17
Levered Free Cash Flow
-86.05-140.06-116.82-33.11-
Unlevered Free Cash Flow
-85.82-140.01-116.82-33.11-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
0.080.08---
Cash Income Tax Paid
1.761.760.710.02-
Change in Working Capital
6.1411.26-39.44.079.04